Table 2.
Characteristics | Total | Active & Replicating |
Active & Non-Replicating |
Resolved/Natural Immunity | Vaccinated | Susceptible/ Naïve |
---|---|---|---|---|---|---|
N | n(%) | n(%) | n(%) | n(%) | n(%) | |
100 | 5(5.0) | 9(9.0) | 20(20.0) | 7(7.0) | 59(59.0) | |
Sex | ||||||
Male | 76 | 4(5.3) | 6(7.9) | 16(21.1) | 6(7.9) | 44(57.9) |
Female | 24 | 1(4.2) | 3(12.5) | 4(16.7) | 1(4.2) | 15(62.5) |
History of IV Drug Use | ||||||
Yes | 33 | 2(6.1) | 3(9.1) | 10(30.3) | 1(3.1) | 17(51.5) |
No | 67 | 3(4.5) | 6(9.0) | 10(14.9) | 6(9.0) | 42(62.7) |
HB Vaccination Status | ||||||
Yes | 9 | 0(0.0) | 0(0.0) | 0(0.0) | 7(77.8) | 2(22.22) |
No | 91 | 5(5.5) | 9(9.9) | 20(22.0) | 0(0.0) | 57(62.6) |
Blood Transfusion History | ||||||
Yes | 7 | 0(0.0) | 1(14.3) | 4(57.1) | 1(14.3) | 1(14.3) |
No | 93 | 5(5.4) | 8(8.6) | 16(17.2) | 6(6.5) | 58(62.4) |